Detalhe da pesquisa
1.
Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease.
Bioorg Med Chem Lett
; 28(10): 1846-1848, 2018 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29691139